newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.
business/news//Republic World
Indian equity markets ended lower on Wednesday, September 24.
Tata Steel has infused Rs 4,054.66 crore into T Steel Holdings, raising 2025 investment to $460 million.
KEY POINTS
Glenmark Specialty S.A. signed an exclusive license deal with Hengrui Pharma for Trastuzumab Rezetecan.
Akzo Nobel India promoter sold 5% stake; Nippon India and WF Asian Smaller Companies Fund acquired large portions.
NCLT has approved the merger of Piramal Enterprises with Piramal Finance, with Anand Piramal as new chair.
Indian equity markets ended lower on Wednesday, September 24. The Nifty 50 fell 113 points (0.45%) to 25,057, while the Sensex dropped 387 points (0.47%) to 81,715.63, tracking muted global cues and mixed corporate earnings.
Stocks To Watch Today
Tata Steel
Tata Steel has increased its investment in T Steel Holdings (TSHP) through a fresh capital infusion. The company subscribed to 457.7 crore equity shares worth Rs 4,054.66 crore. Each share carries a face value of USD 0.1005, taking Tata Steel’s total 2025 investment in TSHP to $460 million.
Waaree Energies
Waaree Energies has infused Rs 300 crore into Waaree Energy Storage Solutions (WESSPL) via a rights issue. The company issued 60 crore partly paid-up equity shares at Rs 10 each, paying Rs 5 upfront, with the balance to be collected later.
Akzo Nobel India
Promoter Imperial Chemical Industries sold 5% of Akzo Nobel India in a block transaction valued at Rs 765 crore. Shares changed hands at an average price of Rs 3,358.8. Institutional investors were active, with Nippon India acquiring 1.8% for Rs 274 crore and WF Asian Smaller Companies Fund picking 1.2% for Rs 174 crore.
Glenmark Pharma
Glenmark Pharmaceuticals subsidiary Glenmark Specialty S.A. signed an exclusive license and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a next-generation HER2-targeting antibody drug conjugate.
Upfront payment: $18 million
Milestone payments: Up to $1.093 billion
Royalties: Based on net sales in the licensed territory
Poly Medicure
Poly Medicure, a leading medical device company, has agreed to acquire Medistream SA, including Citieffe SRL and subsidiaries in the US and Mexico, in a deal valued at Rs 324 crore.
Piramal Enterprises
The National Company Law Tribunal (NCLT) approved the merger of Piramal Enterprises with its subsidiary Piramal Finance. Post-merger, Anand Piramal will chair Piramal Finance, while Ajay Piramal continues to lead the group, and Swati Piramal retains her role as vice-chair.
Indian Hotels
Indian Hotels announced plans to expand its luxury footprint with a new Taj hotel in Visakhapatnam, Andhra Pradesh, featuring 310 rooms.
Birla Corp
RCCPL Private, a Birla Corporation subsidiary, secured the Kanpa-Junapani limestone block in Adilabad, Telangana, at 87.05% of the base price.
IPOs Today
SME Listing - JD Cables
Mainboard Listings - Ivalue Infosolutions